Indo National Limited has made a regulatory disclosure pursuant to Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015, and the SEBI master circular dated November 11, 2024 (SEBI/HO/CFD/PoD2/CIR/P/0155).
Transaction Details
- Investment Amount: ₹25,01,968
- Shares Acquired: 178 equity shares
- Price Per Share: ₹14,056 (based on valuation report by registered valuer dated August 21, 2026)
- Additional Stake Acquired: 0.41% of paid-up share capital on fully diluted basis
- Total Holding Post-Investment: 62.28% stake in MMSPL
- Consideration Type: Cash consideration
- Completion Timeline: Up to FY 2027-28
Target Company Information
- Name: Medcuore Medical Solutions Private Ltd
- Date of Incorporation: June 7, 2020
- Business: Manufacturing, distribution and services related to Air Monitoring Systems and Air Purifiers
- Geographic Presence: India
- Turnover History:
- FY24: ₹47,68,000
- FY25: ₹35,41,484
- FY26: ₹1,45,60,000
Transaction Rationale
The investment object is to facilitate business growth, generate revenue, and earn profit due to expansion of business.
Regulatory and Governance Aspects
- Related Party Status: The acquisition does not fall under related party transaction
- Promoter/Promoter Group Interest: None of the promoter/promoter group/group companies have any interest in MMSPL
- Government Approvals Required: None
- Valuation Basis: Registered valuer report dated August 21, 2026
Financial Impact
The investment represents a cash outflow of ₹25,01,968 and increases the company's stake in MMSPL from approximately 61.87% to 62.28% on a fully diluted basis.